Judy Potashkin - Publications


48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Potashkin JA, Bottero V, Santiago JA, Quinn JP. Bioinformatic Analysis Reveals Phosphodiesterase 4D-Interacting Protein as a Key Frontal Cortex Dementia Switch Gene. International Journal of Molecular Sciences. 21. PMID 32471155 DOI: 10.3390/ijms21113787  0.4
2019 Potashkin JA, Bottero V, Santiago JA, Quinn JP. Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer's patients. Plos One. 14: e0222921. PMID 31545826 DOI: 10.1371/journal.pone.0222921  0.4
2017 Santiago JA, Potashkin JA. Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson' Disease. Frontiers in Aging Neuroscience. 9: 73. PMID 28424608 DOI: 10.3389/fnagi.2017.00073  0.4
2016 Santiago JA, Littlefield AM, Potashkin JA. Integrative transcriptomic meta-analysis of Parkinson's disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson's disease. Scientific Reports. 6: 34579. PMID 27680512 DOI: 10.1038/srep34579  0.4
2015 Santiago JA, Potashkin JA. Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients. Plos One. 10: e0142582. PMID 26566043 DOI: 10.1371/journal.pone.0142582  0.4
2015 Santiago JA, Potashkin JA. Reply to Liu et al.: HNF4A and PTBP1 expression in the brain of neurodegenerative disease patients. Proceedings of the National Academy of Sciences of the United States of America. 112: E3976. PMID 26124150 DOI: 10.1073/pnas.1510113112  0.4
2015 Santiago JA, Potashkin JA. Reply to Toker and Pavlidis: Blood biomarkers for Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 112: E3638. PMID 26106166 DOI: 10.1073/pnas.1508415112  0.4
2015 Santiago JA, Potashkin JA. Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 112: 2257-62. PMID 25646437 DOI: 10.1073/pnas.1423573112  0.4
2014 Santiago JA, Potashkin JA. Current Challenges Towards the Development of a Blood Test for Parkinson's Disease. Diagnostics (Basel, Switzerland). 4: 153-64. PMID 26852683 DOI: 10.3390/diagnostics4040153  0.4
2014 Santiago JA, Potashkin JA. A network approach to clinical intervention in neurodegenerative diseases. Trends in Molecular Medicine. 20: 694-703. PMID 25455073 DOI: 10.1016/j.molmed.2014.10.002  0.4
2014 Santiago JA, Scherzer CR, Potashkin JA. Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease. Plos One. 9: e109042. PMID 25279756 DOI: 10.1371/journal.pone.0109042  0.4
2014 Santiago JA, Potashkin JA. System-based approaches to decode the molecular links in Parkinson's disease and diabetes. Neurobiology of Disease. 72: 84-91. PMID 24718034 DOI: 10.1016/j.nbd.2014.03.019  0.4
2014 Seidl SE, Santiago JA, Bilyk H, Potashkin JA. The emerging role of nutrition in Parkinson's disease. Frontiers in Aging Neuroscience. 6: 36. PMID 24639650 DOI: 10.3389/fnagi.2014.00036  0.4
2014 Santiago JA, Potashkin JA. A network approach to diagnostic biomarkers in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 550-5. PMID 24347522 DOI: 10.1002/mds.25761  0.4
2013 Santiago JA, Potashkin JA. Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes. Plos One. 8: e83940. PMID 24376773 DOI: 10.1371/journal.pone.0083940  0.4
2013 Santiago JA, Scherzer CR, Potashkin JA, Hyman BT, Ivinson AJ, Trisini-Lipsanopoulos A, Dhima K, Bayer S, Lockhart KC, Yi T, Liao Z, Hoesing AN, Duong K, Roderick S, Sudarsky LR, et al. Specific splice variants are associated with Parkinson's disease Movement Disorders. 28: 1724-1727. PMID 24108702 DOI: 10.1002/mds.25635  0.4
2013 Santiago JA, Potashkin JA. Shared dysregulated pathways lead to Parkinson's disease and diabetes. Trends in Molecular Medicine. 19: 176-86. PMID 23375873 DOI: 10.1016/j.molmed.2013.01.002  0.4
2012 Potashkin JA, Santiago JA, Ravina BM, Watts A, Leontovich AA. Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients. Plos One. 7: e43595. PMID 22952715 DOI: 10.1371/journal.pone.0043595  0.4
2011 Seidl SE, Potashkin JA. The promise of neuroprotective agents in Parkinson's disease. Frontiers in Neurology. 2: 68. PMID 22125548 DOI: 10.3389/fneur.2011.00068  0.4
2010 Potashkin JA, Blume SR, Runkle NK. Limitations of animal models of Parkinson's disease. Parkinson's Disease. 2011: 658083. PMID 21209719 DOI: 10.4061/2011/658083  0.4
2010 Wu JY, Potashkin JA. Alternative Splicing in the Nervous System Encyclopedia of Neuroscience. 245-251. DOI: 10.1016/B978-008045046-9.00172-8  0.4
2008 Zhou L, Qi X, Potashkin JA, Abdul-Karim FW, Gorodeski GI. MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript. The Journal of Biological Chemistry. 283: 28274-86. PMID 18682393 DOI: 10.1074/jbc.M802663200  0.4
2008 Meredith GE, Totterdell S, Potashkin JA, Surmeier DJ. Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism & Related Disorders. 14: S112-5. PMID 18585085 DOI: 10.1016/j.parkreldis.2008.04.012  0.4
2007 Potashkin JA, Kang UJ, Loomis PA, Jodelka FM, Ding Y, Meredith GE. MPTP administration in mice changes the ratio of splice isoforms of fosB and rgs9. Brain Research. 1182: 1-10. PMID 17936734 DOI: 10.1016/J.Brainres.2007.08.080  0.4
2007 Marinescu V, Loomis PA, Ehmann S, Beales M, Potashkin JA. Regulation of retention of FosB intron 4 by PTB. Plos One. 2: e828. PMID 17786200 DOI: 10.1371/Journal.Pone.0000828  0.4
2007 Li X, Qi X, Zhou L, Catera D, Rote NS, Potashkin J, Abdul-Karim FW, Gorodeski GI. Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells. Gynecologic Oncology. 106: 233-43. PMID 17482244 DOI: 10.1016/j.ygyno.2007.03.032  0.4
2007 Alibhai IN, Green TA, Potashkin JA, Nestler EJ. Regulation of fosB and DeltafosB mRNA expression: in vivo and in vitro studies. Brain Research. 1143: 22-33. PMID 17324382 DOI: 10.1016/J.Brainres.2007.01.069  0.4
2006 Potashkin JA, Meredith GE. The role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease. Antioxidants & Redox Signaling. 8: 144-51. PMID 16487048 DOI: 10.1089/ars.2006.8.144  0.4
2001 Ochotorena IL, Hirata D, Kominami K, Potashkin J, Sahin F, Wentz-Hunter K, Gould KL, Sato K, Yoshida Y, Vardy L, Toda T. Conserved Wat1/Pop3 WD-repeat protein of fission yeast secures genome stability through microtubule integrity and may be involved in mRNA maturation. Journal of Cell Science. 114: 2911-20. PMID 11686295  0.4
2000 Käufer NF, Potashkin J. Analysis of the splicing machinery in fission yeast: a comparison with budding yeast and mammals. Nucleic Acids Research. 28: 3003-10. PMID 10931913  0.4
2000 Payne WE, Kaiser CA, Bevis BJ, Soderholm J, Fu D, Sears IB, Glick BS. Isolation of Pichia pastoris genes involved in ER-to-Golgi transport. Yeast (Chichester, England). 16: 979-93. PMID 10923020 DOI: 10.1002/1097-0061(200008)16:11<979::Aid-Yea594>3.0.Co;2-C  0.4
1998 Potashkin J, Kim D, Fons M, Humphrey T, Frendewey D. Cell-division-cycle defects associated with fission yeast pre-mRNA splicing mutants. Current Genetics. 34: 153-63. PMID 9745017 DOI: 10.1007/s002940050381  0.4
1998 Gozani O, Potashkin J, Reed R. A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site. Molecular and Cellular Biology. 18: 4752-60. PMID 9671485 DOI: 10.1128/Mcb.18.8.4752  0.4
1997 McKinney R, Wentz-Hunter K, Schmidt H, Potashkin J. Molecular characterization of a novel fission yeast gene spUAP2 that interacts with the splicing factor spU2AF59. Current Genetics. 32: 323-30. PMID 9371883 DOI: 10.1007/s002940050284  0.4
1996 Potashkin J, Wentz-Hunter K, Callaci J. BTF3 is evolutionarily conserved in fission yeast. Biochimica Et Biophysica Acta. 1308: 182-4. PMID 8809106 DOI: 10.1016/0167-4781(96)00114-5  0.4
1996 Wentz-Hunter K, Potashkin J. The small subunit of the splicing factor U2AF is conserved in fission yeast. Nucleic Acids Research. 24: 1849-54. PMID 8657565 DOI: 10.1093/nar/24.10.1849  0.4
1995 Wentz-Hunter K, Potashkin J. The evolutionary conservation of the splicing apparatus between fission yeast and man. Nucleic Acids Symposium Series. 226-8. PMID 8643378  0.4
1993 Potashkin J, Naik K, Wentz-Hunter K. U2AF homolog required for splicing in vivo. Science (New York, N.Y.). 262: 573-5. PMID 8211184  0.4
1990 Potashkin J, Frendewey D. A mutation in a single gene of Schizosaccharomyces pombe affects the expression of several snRNAs and causes defects in RNA processing. The Embo Journal. 9: 525-34. PMID 2406130  0.4
1990 Frendewey D, Barta I, Gillespie M, Potashkin J. Schizosaccharomyces U6 genes have a sequence within their introns that matches the B box consensus of tRNA internal promoters. Nucleic Acids Research. 18: 2025-32. PMID 2336389 DOI: 10.1093/Nar/18.8.2025  0.4
1990 Potashkin JA, Derby RJ, Spector DL. Differential distribution of factors involved in pre-mRNA processing in the yeast cell nucleus. Molecular and Cellular Biology. 10: 3524-34. PMID 2192258 DOI: 10.1128/Mcb.10.7.3524  0.4
1989 Potashkin J, Frendewey D. Splicing of the U6 RNA precursor is impaired in fission yeast pre-mRNA splicing mutants. Nucleic Acids Research. 17: 7821-31. PMID 2798130  0.4
1989 Potashkin J, Li R, Frendewey D. Pre-mRNA splicing mutants of Schizosaccharomyces pombe. The Embo Journal. 8: 551-9. PMID 2721492  0.4
1988 Potashkin JA, Beach DH. Multiple phosphorylated forms of the product of the fission yeast cell division cycle gene cdc2+. Current Genetics. 14: 235-40. PMID 3058333 DOI: 10.1007/BF00376743  0.4
1987 Draetta G, Brizuela L, Potashkin J, Beach D. Identification of p34 and p13, human homologs of the cell cycle regulators of fission yeast encoded by cdc2+ and suc1+. Cell. 50: 319-25. PMID 3297353 DOI: 10.1016/0092-8674(87)90227-3  0.4
1986 Potashkin JA, Huberman JA. Characterization of DNA sequences associated with residual nuclei of Saccharomyces cerevisiae. Experimental Cell Research. 165: 29-40. PMID 3519258 DOI: 10.1016/0014-4827(86)90530-6  0.4
1984 Potashkin JA, Zeigel RF, Huberman JA. Isolation and initial characterization of residual nuclear structures from yeast. Experimental Cell Research. 153: 374-88. PMID 6203771 DOI: 10.1016/0014-4827(84)90607-4  0.4
1980 Potashkin JA, Schlegel RA. A possible mechanism by which SV40 T-antigen stimulates rRNA synthesis. Cell Biology International Reports. 4: 399-406. PMID 6156015 DOI: 10.1016/0309-1651(80)90221-0  0.4
Show low-probability matches.